Who is this event intended for? This event is intended for people who create data visualizations as well as customers who work with data visualization developers to make their data come to life.
What is the benefit of attending? This is a fun event where the audience will participate and become part of an experiment using polls and quick exposure to images (~250 milliseconds) to validate some of the principles taught in this course. This event will benefit data visualization developers and customers by teaching them how to leverage gestalt principles and pre-attentive processing in selecting aesthetics to maximize the effectiveness of their data visualizations.
Registration
You can now register for this event. This event is free of charge to both Members and Non-Members of PSI.
To register for the session, please click here.
Overview
The visual cortex can recognize certain “targets” and “borders”, based on variations in visual cues such as shape and color, within 250 milliseconds; this is called pre-attentive processing. This is faster than it takes to become conscious of the image. When combining visual cues, conjunctive visual cues, the pre-attentive qualities are generally lost. We will illustrate these concepts through an empirical experiment with the audience. The audience will be expected to participate and identify targets and borders within 250 milliseconds. We will cover what types of visual cues are conducive to pre-attentive processing and how to incorporate these concepts in your data visualizations. Similarly, the study of gestalt principles from psychology, seeing meaning in a purposeful arrangement of design elements, can be leveraged for effective data visualizations. We will also discuss the hierarchies of perception and how this applies to data visualization.
Speaker details
Zachary Skrivanek
Dr. Skrivanek graduated with a Ph.D. in biostatistics from Ohio State University and a B.S. from Cornell University, where he studied exploratory data analysis under Professor Velleman, a protégé of John W. Tukey, who invented a number of statistical graphics including the box plot. He joined Eli Lilly in 2002 where he contributed to the development of endocrine-related medicines and related biomarkers in early clinical phase drug development. He later transitioned to a product team in late phase clinical development as the lead statistician and developed and successfully implemented an innovative Bayesian adaptive, seamless phase 2/3 study which selected the doses for the entire program utilizing a clinical utility index. Dr. Skrivanek heavily leveraged data visualization to communicate the operating characteristics of the design as well as the results of the study.
He is currently leading an effort to make visual analytics and good data visualization practices in general an integral part of drug development at Eli Lilly and the industry in general. He is involved in a number of external collaborations focused on advancing drug development through visual analytics including co-leading a subproject in PHUSE, on “Interactive Data Visualizations for Decision Making in Submissions”, and contributing to an ASA-DIA working group on interactive safety graphics and an organizing member on a PSI (Statistics in the Pharmaceutical Industry) Special Interest Group (SIG) which hosts a monthly event, “Wonderful Wednesdays” where members are given data visualization challenges that they must solve for the following month and the solutions are critiqued by the panel based on good data visualization principles.
Who is this event intended for? This event is intended for people who create data visualizations as well as customers who work with data visualization developers to make their data come to life.
What is the benefit of attending? This is a fun event where the audience will participate and become part of an experiment using polls and quick exposure to images (~250 milliseconds) to validate some of the principles taught in this course. This event will benefit data visualization developers and customers by teaching them how to leverage gestalt principles and pre-attentive processing in selecting aesthetics to maximize the effectiveness of their data visualizations.
Registration
You can now register for this event. This event is free of charge to both Members and Non-Members of PSI.
To register for the session, please click here.
Overview
The visual cortex can recognize certain “targets” and “borders”, based on variations in visual cues such as shape and color, within 250 milliseconds; this is called pre-attentive processing. This is faster than it takes to become conscious of the image. When combining visual cues, conjunctive visual cues, the pre-attentive qualities are generally lost. We will illustrate these concepts through an empirical experiment with the audience. The audience will be expected to participate and identify targets and borders within 250 milliseconds. We will cover what types of visual cues are conducive to pre-attentive processing and how to incorporate these concepts in your data visualizations. Similarly, the study of gestalt principles from psychology, seeing meaning in a purposeful arrangement of design elements, can be leveraged for effective data visualizations. We will also discuss the hierarchies of perception and how this applies to data visualization.
Speaker details
Zachary Skrivanek
Dr. Skrivanek graduated with a Ph.D. in biostatistics from Ohio State University and a B.S. from Cornell University, where he studied exploratory data analysis under Professor Velleman, a protégé of John W. Tukey, who invented a number of statistical graphics including the box plot. He joined Eli Lilly in 2002 where he contributed to the development of endocrine-related medicines and related biomarkers in early clinical phase drug development. He later transitioned to a product team in late phase clinical development as the lead statistician and developed and successfully implemented an innovative Bayesian adaptive, seamless phase 2/3 study which selected the doses for the entire program utilizing a clinical utility index. Dr. Skrivanek heavily leveraged data visualization to communicate the operating characteristics of the design as well as the results of the study.
He is currently leading an effort to make visual analytics and good data visualization practices in general an integral part of drug development at Eli Lilly and the industry in general. He is involved in a number of external collaborations focused on advancing drug development through visual analytics including co-leading a subproject in PHUSE, on “Interactive Data Visualizations for Decision Making in Submissions”, and contributing to an ASA-DIA working group on interactive safety graphics and an organizing member on a PSI (Statistics in the Pharmaceutical Industry) Special Interest Group (SIG) which hosts a monthly event, “Wonderful Wednesdays” where members are given data visualization challenges that they must solve for the following month and the solutions are critiqued by the panel based on good data visualization principles.
Who is this event intended for? This event is intended for people who create data visualizations as well as customers who work with data visualization developers to make their data come to life.
What is the benefit of attending? This is a fun event where the audience will participate and become part of an experiment using polls and quick exposure to images (~250 milliseconds) to validate some of the principles taught in this course. This event will benefit data visualization developers and customers by teaching them how to leverage gestalt principles and pre-attentive processing in selecting aesthetics to maximize the effectiveness of their data visualizations.
Registration
You can now register for this event. This event is free of charge to both Members and Non-Members of PSI.
To register for the session, please click here.
Overview
The visual cortex can recognize certain “targets” and “borders”, based on variations in visual cues such as shape and color, within 250 milliseconds; this is called pre-attentive processing. This is faster than it takes to become conscious of the image. When combining visual cues, conjunctive visual cues, the pre-attentive qualities are generally lost. We will illustrate these concepts through an empirical experiment with the audience. The audience will be expected to participate and identify targets and borders within 250 milliseconds. We will cover what types of visual cues are conducive to pre-attentive processing and how to incorporate these concepts in your data visualizations. Similarly, the study of gestalt principles from psychology, seeing meaning in a purposeful arrangement of design elements, can be leveraged for effective data visualizations. We will also discuss the hierarchies of perception and how this applies to data visualization.
Speaker details
Zachary Skrivanek
Dr. Skrivanek graduated with a Ph.D. in biostatistics from Ohio State University and a B.S. from Cornell University, where he studied exploratory data analysis under Professor Velleman, a protégé of John W. Tukey, who invented a number of statistical graphics including the box plot. He joined Eli Lilly in 2002 where he contributed to the development of endocrine-related medicines and related biomarkers in early clinical phase drug development. He later transitioned to a product team in late phase clinical development as the lead statistician and developed and successfully implemented an innovative Bayesian adaptive, seamless phase 2/3 study which selected the doses for the entire program utilizing a clinical utility index. Dr. Skrivanek heavily leveraged data visualization to communicate the operating characteristics of the design as well as the results of the study.
He is currently leading an effort to make visual analytics and good data visualization practices in general an integral part of drug development at Eli Lilly and the industry in general. He is involved in a number of external collaborations focused on advancing drug development through visual analytics including co-leading a subproject in PHUSE, on “Interactive Data Visualizations for Decision Making in Submissions”, and contributing to an ASA-DIA working group on interactive safety graphics and an organizing member on a PSI (Statistics in the Pharmaceutical Industry) Special Interest Group (SIG) which hosts a monthly event, “Wonderful Wednesdays” where members are given data visualization challenges that they must solve for the following month and the solutions are critiqued by the panel based on good data visualization principles.
Who is this event intended for? This event is intended for people who create data visualizations as well as customers who work with data visualization developers to make their data come to life.
What is the benefit of attending? This is a fun event where the audience will participate and become part of an experiment using polls and quick exposure to images (~250 milliseconds) to validate some of the principles taught in this course. This event will benefit data visualization developers and customers by teaching them how to leverage gestalt principles and pre-attentive processing in selecting aesthetics to maximize the effectiveness of their data visualizations.
Registration
You can now register for this event. This event is free of charge to both Members and Non-Members of PSI.
To register for the session, please click here.
Overview
The visual cortex can recognize certain “targets” and “borders”, based on variations in visual cues such as shape and color, within 250 milliseconds; this is called pre-attentive processing. This is faster than it takes to become conscious of the image. When combining visual cues, conjunctive visual cues, the pre-attentive qualities are generally lost. We will illustrate these concepts through an empirical experiment with the audience. The audience will be expected to participate and identify targets and borders within 250 milliseconds. We will cover what types of visual cues are conducive to pre-attentive processing and how to incorporate these concepts in your data visualizations. Similarly, the study of gestalt principles from psychology, seeing meaning in a purposeful arrangement of design elements, can be leveraged for effective data visualizations. We will also discuss the hierarchies of perception and how this applies to data visualization.
Speaker details
Zachary Skrivanek
Dr. Skrivanek graduated with a Ph.D. in biostatistics from Ohio State University and a B.S. from Cornell University, where he studied exploratory data analysis under Professor Velleman, a protégé of John W. Tukey, who invented a number of statistical graphics including the box plot. He joined Eli Lilly in 2002 where he contributed to the development of endocrine-related medicines and related biomarkers in early clinical phase drug development. He later transitioned to a product team in late phase clinical development as the lead statistician and developed and successfully implemented an innovative Bayesian adaptive, seamless phase 2/3 study which selected the doses for the entire program utilizing a clinical utility index. Dr. Skrivanek heavily leveraged data visualization to communicate the operating characteristics of the design as well as the results of the study.
He is currently leading an effort to make visual analytics and good data visualization practices in general an integral part of drug development at Eli Lilly and the industry in general. He is involved in a number of external collaborations focused on advancing drug development through visual analytics including co-leading a subproject in PHUSE, on “Interactive Data Visualizations for Decision Making in Submissions”, and contributing to an ASA-DIA working group on interactive safety graphics and an organizing member on a PSI (Statistics in the Pharmaceutical Industry) Special Interest Group (SIG) which hosts a monthly event, “Wonderful Wednesdays” where members are given data visualization challenges that they must solve for the following month and the solutions are critiqued by the panel based on good data visualization principles.
Who is this event intended for? This event is intended for people who create data visualizations as well as customers who work with data visualization developers to make their data come to life.
What is the benefit of attending? This is a fun event where the audience will participate and become part of an experiment using polls and quick exposure to images (~250 milliseconds) to validate some of the principles taught in this course. This event will benefit data visualization developers and customers by teaching them how to leverage gestalt principles and pre-attentive processing in selecting aesthetics to maximize the effectiveness of their data visualizations.
Registration
You can now register for this event. This event is free of charge to both Members and Non-Members of PSI.
To register for the session, please click here.
Overview
The visual cortex can recognize certain “targets” and “borders”, based on variations in visual cues such as shape and color, within 250 milliseconds; this is called pre-attentive processing. This is faster than it takes to become conscious of the image. When combining visual cues, conjunctive visual cues, the pre-attentive qualities are generally lost. We will illustrate these concepts through an empirical experiment with the audience. The audience will be expected to participate and identify targets and borders within 250 milliseconds. We will cover what types of visual cues are conducive to pre-attentive processing and how to incorporate these concepts in your data visualizations. Similarly, the study of gestalt principles from psychology, seeing meaning in a purposeful arrangement of design elements, can be leveraged for effective data visualizations. We will also discuss the hierarchies of perception and how this applies to data visualization.
Speaker details
Zachary Skrivanek
Dr. Skrivanek graduated with a Ph.D. in biostatistics from Ohio State University and a B.S. from Cornell University, where he studied exploratory data analysis under Professor Velleman, a protégé of John W. Tukey, who invented a number of statistical graphics including the box plot. He joined Eli Lilly in 2002 where he contributed to the development of endocrine-related medicines and related biomarkers in early clinical phase drug development. He later transitioned to a product team in late phase clinical development as the lead statistician and developed and successfully implemented an innovative Bayesian adaptive, seamless phase 2/3 study which selected the doses for the entire program utilizing a clinical utility index. Dr. Skrivanek heavily leveraged data visualization to communicate the operating characteristics of the design as well as the results of the study.
He is currently leading an effort to make visual analytics and good data visualization practices in general an integral part of drug development at Eli Lilly and the industry in general. He is involved in a number of external collaborations focused on advancing drug development through visual analytics including co-leading a subproject in PHUSE, on “Interactive Data Visualizations for Decision Making in Submissions”, and contributing to an ASA-DIA working group on interactive safety graphics and an organizing member on a PSI (Statistics in the Pharmaceutical Industry) Special Interest Group (SIG) which hosts a monthly event, “Wonderful Wednesdays” where members are given data visualization challenges that they must solve for the following month and the solutions are critiqued by the panel based on good data visualization principles.
Who is this event intended for? This event is intended for people who create data visualizations as well as customers who work with data visualization developers to make their data come to life.
What is the benefit of attending? This is a fun event where the audience will participate and become part of an experiment using polls and quick exposure to images (~250 milliseconds) to validate some of the principles taught in this course. This event will benefit data visualization developers and customers by teaching them how to leverage gestalt principles and pre-attentive processing in selecting aesthetics to maximize the effectiveness of their data visualizations.
Registration
You can now register for this event. This event is free of charge to both Members and Non-Members of PSI.
To register for the session, please click here.
Overview
The visual cortex can recognize certain “targets” and “borders”, based on variations in visual cues such as shape and color, within 250 milliseconds; this is called pre-attentive processing. This is faster than it takes to become conscious of the image. When combining visual cues, conjunctive visual cues, the pre-attentive qualities are generally lost. We will illustrate these concepts through an empirical experiment with the audience. The audience will be expected to participate and identify targets and borders within 250 milliseconds. We will cover what types of visual cues are conducive to pre-attentive processing and how to incorporate these concepts in your data visualizations. Similarly, the study of gestalt principles from psychology, seeing meaning in a purposeful arrangement of design elements, can be leveraged for effective data visualizations. We will also discuss the hierarchies of perception and how this applies to data visualization.
Speaker details
Zachary Skrivanek
Dr. Skrivanek graduated with a Ph.D. in biostatistics from Ohio State University and a B.S. from Cornell University, where he studied exploratory data analysis under Professor Velleman, a protégé of John W. Tukey, who invented a number of statistical graphics including the box plot. He joined Eli Lilly in 2002 where he contributed to the development of endocrine-related medicines and related biomarkers in early clinical phase drug development. He later transitioned to a product team in late phase clinical development as the lead statistician and developed and successfully implemented an innovative Bayesian adaptive, seamless phase 2/3 study which selected the doses for the entire program utilizing a clinical utility index. Dr. Skrivanek heavily leveraged data visualization to communicate the operating characteristics of the design as well as the results of the study.
He is currently leading an effort to make visual analytics and good data visualization practices in general an integral part of drug development at Eli Lilly and the industry in general. He is involved in a number of external collaborations focused on advancing drug development through visual analytics including co-leading a subproject in PHUSE, on “Interactive Data Visualizations for Decision Making in Submissions”, and contributing to an ASA-DIA working group on interactive safety graphics and an organizing member on a PSI (Statistics in the Pharmaceutical Industry) Special Interest Group (SIG) which hosts a monthly event, “Wonderful Wednesdays” where members are given data visualization challenges that they must solve for the following month and the solutions are critiqued by the panel based on good data visualization principles.
Upcoming Events
PSI Introduction to Industry Training (ITIT) Course - 2026/2027
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This webinar brings together three bitesize complementary sessions to help PSI contributors create conference presentations and posters that communicate clearly and inclusively. Participants will explore how to refine their message, prepare materials effectively, and adopt practical habits that support confident, accessible delivery. A focused, supportive session designed to elevate every contribution.
Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry. This month’s session, “Graphics Basics,” will introduce the fundamentals of producing graphics using the ggplot2 package.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Join our Health Technology Assessment (HTA) European Special Interest Group (ESIG) for a webinar on the strategic role of statisticians in the Joint Clinical Assessment (JCA). The introduction of the JCA marks a new era for evidence generation and market access in Europe. As HTA requirements become more harmonized and methodologically demanding, the role of statisticians has evolved far beyond data analysis. Today, statistical expertise is central to shaping clinical development strategies, designing robust comparative evidence, and ensuring that submissions withstand the scrutiny of EU-level assessors. In this webinar, we explore how statisticians contribute strategically to successful JCA outcomes.
Statisticians in the Age of AI: On Route to Strategic Partnership
A 90-minute webinar featuring two case studies from Bayer and Roche demonstrating how statisticians successfully integrated into AI programs, followed by interactive discussion on strategies for elevating statistical expertise in the AI era.
Enhancing Clinical Study Reporting with the Estimand Framework
Join us for an insightful webinar where we explore practical strategies for applying the estimand framework in clinical study reporting. Drawing on real-world experiences and case studies, we will share recommendations to help you:
• Understand the role of estimands in improving transparency and interpretation of trial results.
• Navigate common challenges in implementing the framework during reporting.
• Apply best practices to enhance regulatory submissions, webposting in public registries (clinicaltrials.gov/CTIS), and scientific publications.
Whether you are involved in clinical trial design, data analysis, or regulatory submissions, this session will provide actionable guidance to realize the full potential of the estimand framework.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
GSK - Statistics Director - Vaccines and Infectious Disease
We are seeking an experienced and visionary Statistics Director to join our Team and lead strategic statistical innovation across GSK’s Vaccines and Infectious Disease portfolio.
As a Senior Biostatistician I at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
As a Statistical Scientist at ICON, you will play a pivotal role in designing and analyzing clinical trials, interpreting complex medical data, and contributing to the advancement of innovative treatments and therapies.
We have an exciting opportunity for an Associate Director, Biostatistics to join a passionate team within Advanced Quantitative Sciences – Full Development.
: We have an exciting opportunity for an Associate Director (AD), Statistical Programming, to join a passionate team within Advanced Quantitative Sciences- Development.
Novartis - Senior Principal Statistical Programmer
We have an exciting opportunity for a Senior Principal Statistical Programmer, to join a passionate team within Advanced Quantitative Sciences – Development.
Pierre Fabre - Clinical Development Safety Statistics Expert M/F
We are seeking a highly skilled and proactive Clinical Development Safety Statistics Expert to join our Biometry Department and the Biometry Leadership Team based in Toulouse (31, Oncopole) or Boulogne (92).
Pierre Fabre - Lead Statistician – Real World Evidence -CDI- M/F
Pierre Fabre Laboratories are hiring a highly skilled and experienced Lead Statistician – Real World Evidence (RWE) to join the Biometry Department, part of the Data Science & Biometry Department, based in Toulouse (Oncopôle) or Boulogne.
Pierre Fabre - Lead Statistician- Clinical Trials M/F
We are seeking a highly skilled and experienced Lead Statistician in Clinical Trials to join our Biometry Department based in Toulouse (31, Oncopole) or Boulogne (92).
We are looking for Senior Statistical Programmers in the UK to join Veramed, where you'll deliver high-impact programming solutions in an FSP-style capacity, while advancing your career in a supportive, growth-driven environment.